These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8923576)

  • 1. Pharmacological manipulation of ultrasound induced defence behaviour in the rat.
    Beckett SR; Aspley S; Graham M; Marsden CA
    Psychopharmacology (Berl); 1996 Oct; 127(4):384-90. PubMed ID: 8923576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity.
    Bilkei-Gorzó A; Gyertyán I; Lévay G
    Psychopharmacology (Berl); 1998 Apr; 136(3):291-8. PubMed ID: 9566815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour.
    Beckett S; Marsden CA
    J Psychopharmacol; 1997; 11(1):35-40. PubMed ID: 9097891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
    Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats.
    Nicolas LB; Klein S; Prinssen EP
    Psychopharmacology (Berl); 2007 Oct; 194(2):243-52. PubMed ID: 17589832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
    Campos KF; Amaral VC; Rico JL; Miguel TT; Nunes-de-Souza RL
    Behav Brain Res; 2013 Mar; 240():160-70. PubMed ID: 23195112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK; Heaton M; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors.
    Shannon HE; Lutz EA
    Psychopharmacology (Berl); 2000 Mar; 149(1):93-7. PubMed ID: 10789888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
    Shepherd JK; Grewal SS; Fletcher A; Bill DJ; Dourish CT
    Psychopharmacology (Berl); 1994 Sep; 116(1):56-64. PubMed ID: 7862931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does alprazolam, in contrast to diazepam, activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion?
    Eriksson E; Carlsson M; Nilsson C; Söderpalm B
    Life Sci; 1986 Apr; 38(16):1491-8. PubMed ID: 2871466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP).
    Krystal JH; Webb E; Grillon C; Cooney N; Casal L; Morgan CA; Southwick SM; Davis M; Charney DS
    Psychopharmacology (Berl); 1997 Jun; 131(3):207-15. PubMed ID: 9203230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of 5-HT1A receptor agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: a study using the hole-board test.
    Tsuji M; Takeda H; Matsumiya T
    Psychopharmacology (Berl); 2000 Oct; 152(2):157-66. PubMed ID: 11057519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors.
    Chopin P; Pellow S; File SE
    Neuropharmacology; 1986 Jan; 25(1):53-7. PubMed ID: 2869438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197).
    Tallentire D; McRae G; Spedding M; Clark R; Vickery B
    Br J Pharmacol; 1996 May; 118(1):63-72. PubMed ID: 8733577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.